Arthritis Innovation Corporation
Quick facts
Marketed products
- F14 · Immunology / Rheumatology
F14 is a humanized monoclonal antibody that targets and inhibits fibroblast growth factor receptor (FGFR) signaling to reduce inflammatory responses in arthritis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: